Platform overview·06 modules, one case file

The whole matter, in one case file.

TheCounselor turns a raw client interview and a stack of PDFs into a fully-cited chronology, a tested case theory, and a filing-ready pleading — all in the same workspace, all traceable to the page and second they came from.

Walk through the product
6 modules
Documents, Transcripts, Story, Analysis, Theory & Drafts — in one case file
Every fact, cited
Traceable chain from pleading back to transcript second and bundle page
Malaysian format
SOC, SOD, and counterclaims drafted to High Court of Malaya convention
01Documents02Transcripts03Story04Analysis05Theory06Drafts
01Documents

Every bundle, paginated the way the registrar expects.

Import from OneDrive, drop-zone, or email forward. TheCounselor OCRs everything, detects natural bundle breaks, and applies continuous pagination across the bundle — so page 47 in the Story is page 47 in the registrar's copy.

  • §Drag-and-drop, OneDrive sync, or forward-to-email intake
  • §Full-text OCR on scans, handwriting, and mixed-language PDFs
  • §Continuous bundle pagination with registrar-ready index
  • §Search across every page in every bundle in milliseconds
app.thecounselor.ai / cases / 8832-11ac / documents

Tanjung Biotech Sdn Bhd

ActivePlaintiff
Civil · 3 Defendants
⌕Search document contents…
📁Bundle A — Employment & Confidentiality14 docs · pp. 001–247
📄Employment Contract — Dr. Aiman bin Rahman (2019)pp. 001–018OCR'd
📄Non-Disclosure Agreement — Dr. Aiman (2019)pp. 019–026OCR'd
📄Employment Contract — Ms. Sarah Tan, Lead Engineer (2021)pp. 027–044OCR'd
📄Resignation Letter — Dr. Aiman, 14 Mar 2024pp. 045–046OCR'd
📄Exit Interview Transcript — 18 Mar 2024pp. 047–061OCR…
📁▸ Bundle B — Correspondence & Notices23 docs · pp. 248–412
📁▸ Bundle C — Technical & Financial9 docs · pp. 413–574
02Transcripts

Speaker-labelled transcripts, ready in minutes.

Upload the client interview audio. TheCounselor transcribes it verbatim, identifies each speaker by name, and makes every second of the recording searchable, citable, and linkable to the chronology.

  • §Native Bahasa Malaysia / English bilingual transcription
  • §Speaker diarisation — named participants, not "Speaker 1"
  • §Click any second to jump to the audio
  • §Imports from OneDrive, Zoom, or direct upload
app.thecounselor.ai / cases / 8832-11ac / transcripts

Tanjung Biotech Sdn Bhd

ActivePlaintiff
Audio recordings & imported transcripts
🎙Client Interview — Dr. Ong Wei Lin (CTO) · 02 Apr 2026Reviewed
📎 Audio · 68 min 14 sec◎ 1,204 segments◯ 4 participants
00:00:12WLSo — to give you context — we started the Therapeutics Division in 2019, and Dr. Aiman was our first senior hire. He had the keys to everything from day one.
00:00:34MHAnd when did you first notice anything off about his conduct?
00:00:41WLLate February. He started taking leave on Fridays. By the third week, he was missing all-hands. One of the lab techs mentioned seeing him at a café in Bangsar with Sarah on a weekday.
🎙Follow-up call — Ms. Priya Raman (HR Director) · 05 Apr 2026New
📎 Audio · 22 min 48 sec◎ 412 segments◯ 2 participants
03The Story

The case, arranged in date order — every fact sourced.

The Story weaves transcript and documents into a single chronological fact table. Each row points back to the exact bundle page or transcript second it came from. Where the system deduces something that wasn't said out loud, it flags it as an inference — so you always know what's established and what still needs a witness.

  • §Chronological facts grouped by chapter
  • §Every row cites to bundle page or transcript timecode
  • §AI inferences flagged and distinguished from direct evidence
app.thecounselor.ai / cases / 8832-11ac / story

Tanjung Biotech Sdn Bhd

ActivePlaintiff
Chronology — 46 facts across 3 chapters
▾Chapter 1 · Employment & Trust (2019 – 2023)
04 Feb 2019Dr. Aiman bin Rahman joins as Head of R&D.Signs employment contract and separate NDA. Granted Tier-1 access to cell-line repository and assay IP vault.B-A · p.003
11 Aug 2021Ms. Sarah Tan joins as Lead Bioengineer, reporting to Dr. Aiman.Co-signatory on the assay protocol library.B-A · p.027
Q3 2023Aiman named on three Tanjung patent filings.InferredTr. 00:04:21
▸Chapter 2 · Parallel activity (Feb – Mar 2024) — 5 facts
▸Chapter 3 · Competing venture (Apr 2024 – present) — 17 facts
04Legal Analysis

Causes of action, defendants, and the gaps you still have to fill.

TheCounselor maps every plausible cause of action to its legal elements, and every element to the facts in the Story. It proposes each viable defendant with role and exposure, and — most importantly — tells you what evidence is still missing before you can plead it.

  • §Cause-of-action scoring with element-by-element breakdown
  • §Defendant proposals with role and strike-out risk
  • §Critical & medium-priority evidence gaps with suggested follow-ups
  • §Legal remedies mapped to Malaysian authorities
app.thecounselor.ai / cases / 8832-11ac / analysis

Tanjung Biotech Sdn Bhd

ActivePlaintiff
Legal Analysis Version 2 · regenerated 12/04/2026
⎔ Causes of Action (2)
Breach of Fiduciary Duty (Dr. Aiman & Sarah Tan)92%
✓ 6 elements△ 1 risk× 0 blockers
+ Add note to this cause…
Misuse of Trade Secrets & Confidential Information 87%
✓ 4 elements△ 2 risks× 0 blockers
+ Add note to this cause…
☷ Identified Defendants (2)
▸Dr. Aiman bin RahmanNew
▸Ms. Sarah TanNew
⚠ Evidence Gaps (5)Critical (2)Medium (3)
⚠ Critical · No forensic copy of Sarah Tan's workstation.Access logs show a bulk export on 27 Feb 2024 using her credential, but we have no device-level evidence — screenshot metadata, cached files, or USB-attachment records — linking the downloaded assay library to Novacell's current operations. Without this, Defendants can argue credential compromise rather than knowing misappropriation.
“Can you request a forensic image of Ms. Tan's issued laptop before it was re-imaged by IT?”“Do you have MDM logs showing USB devices attached to her machine between 20 Feb and 12 Mar 2024?”“Is there a terminated-device retention policy we can rely on for a preservation order?”
05Case Theory

A tested theory, an alternative in the wings — narrative already planned.

TheCounselor proposes a Primary and an Alternative theory, each scored against the evidence. Approve one, swap to the other, or regenerate. When you're ready, it drafts the Narrative Structure — the story your SOC will actually tell — and the Relief Plan that flows from it.

  • §Primary and alternative theories with confidence scoring
  • §Essential Facts — the load-bearing pleadable points
  • §Narrative structure — the order the SOC will argue
  • §Relief plan with lawyer-review markers for quantum
app.thecounselor.ai / cases / 8832-11ac / theory

Tanjung Biotech Sdn Bhd

ActivePlaintiff
💡 Case Theory
Approved

Primary strategy leverages fiduciary duties and confidentiality obligations owed by Dr. Aiman and Ms. Tan, who used their senior positions to systematically divert confidential cell-line technology to Novacell Therapeutics. The theory is supported by contemporaneous access logs, the resignation timing, and the incorporation of Novacell. An alternative theory under the Contracts Act 1950 (unjust enrichment) is pleaded against salary continuations and equity grants post-resignation.

◉Primary Theory92%
Breach of Fiduciary Duty by Senior Employees

Dr. Aiman and Ms. Tan, occupying fiduciary positions with access to confidential cell-line technology and proprietary assay protocols, breached their duties by incorporating a competing business and diverting the Plaintiff's R&D pipeline while still in employment.

Supported by strong documentary and testimonial evidence. Malaysian courts in Guinness Anchor v Eng Chin Hoe [2010] and similar authorities provide robust remedies including equitable account of profits.

◌Alternative Theory74%
Unjust Enrichment — Contracts Act 1950

Alternatively, the Defendants were unjustly enriched by sign-on bonuses and retention payments totalling RM 340,000 received during periods when they were simultaneously establishing a competing venture.

Plead in the alternative against First and Second Defendants only; separate section required under common law and statutory grounds.

📖 Narrative Structure · drag to reorder
1.The Plaintiff & Its Proprietary Technology — Introduce Tanjung's cell-line research, patent pipeline, and reliance on trade-secret protection.
2.Employment of the First & Second Defendants — Establish senior fiduciary positions, training relationship, benefits conferred.
3.Confidentiality Obligations & Data Access — Define contractual and equitable duties re: cell-line repository.
4.Resignations & Formation of Competing Venture — Chronicle incorporation of Novacell and coordinated departure.
5.Breach of Fiduciary Duty by First & Second Defendants — Plead specific acts: solicitation, diversion, misappropriation.
6.Loss & Damage — Quantify revenue collapse and cost to re-establish.
7.Unjust Enrichment (in the Alternative) — Plead common-law restitution for benefits conferred.
8.Relief — Prayers for damages, injunction, and delivery up.
06Drafts

A Statement of Claim with the evidence chain showing through.

When Theory is approved, TheCounselor drafts the Statement of Claim in High Court of Malaya format. Toggle Internal view to see the evidence tags behind every paragraph — so every factual assertion is traceable to the fact in the Story, the second in the transcript, and the bundle page beneath it.

  • §SOC, SOD, or Counterclaim in proper court format
  • §Internal view with inline evidence tags & lawyer-review flags
  • §Court-Ready view strips the tags for filing
  • §Exports to .docx and print-ready PDF
app.thecounselor.ai / cases / 8832-11ac / drafts

Tanjung Biotech Sdn Bhd

ActivePlaintiff
✎ Internal⎙ Court-Ready
v4 ▾
IN THE HIGH COURT OF MALAYA AT KUALA LUMPUR
(CIVIL DIVISION)
CIVIL SUIT NO: _______________ / 2026
BETWEEN
TANJUNG BIOTECH SDN BHD (Company No. 201801_______)
… PLAINTIFF
AND
1. DR. AIMAN BIN RAHMAN (NRIC No. _________)
… FIRST DEFENDANT

2. MS. SARAH TAN (NRIC No. _________)
… SECOND DEFENDANT

3. NOVACELL THERAPEUTICS SDN BHD (Company No. 202402_______)
… THIRD DEFENDANT
STATEMENT OF CLAIM

1.The Plaintiff is Tanjung Biotech Sdn Bhd, a company duly incorporated in Malaysia, carrying on the business of stem-cell research, development and the provision of related laboratory services to healthcare providers, and at all material times was the registered proprietor of the confidential cell-line repository and proprietary assay protocols pleaded herein. Plaintiff's business & IP Role of company directors & officers ⚑ Lawyer: confirm registered address

2.The First Defendant is Dr. Aiman bin Rahman, at all material times employed by the Plaintiff as Head of Research & Development from 4 February 2019 until 13 April 2024, in which position he owed to the Plaintiff fiduciary duties of loyalty and confidentiality. Aiman's employment & tenure Fiduciary status

3.The Second Defendant is Ms. Sarah Tan, at all material times employed as Lead Bioengineer reporting to the First Defendant from 11 August 2021 until 24 April 2024. Sarah's employment & tenure

4.By a written Non-Disclosure Agreement dated 4 February 2019, the First Defendant covenanted not to use, disclose, or reproduce any confidential information of the Plaintiff for any purpose other than the Plaintiff's business, both during and after his employment. NDA clause 4.2 Confidentiality obligations

Defining principle

The evidence chain is never broken.

One chain runs through every module. A paragraph in the SOC is tied to a pleadable point in the Theory, which is tied to a cause in the Analysis, which is tied to a fact in the Story, which is tied to the transcript second and bundle page it came from. Click any link in the chain — go to the source.

01 · DRAFT
Pleading paragraph

"…the First Defendant owed to the Plaintiff fiduciary duties of loyalty and confidentiality."

SOC ¶ 2
02 · THEORY
Essential fact

Aiman's employment & senior fiduciary role as Head of R&D with Tier-1 IP access.

Theory · Essential #2
03 · ANALYSIS
Cause element

Fiduciary duty — 6 of 6 elements satisfied; confidence 92%.

Analysis · Cause A
04 · STORY
Fact row

"Dr. Aiman joins as Head of R&D. Granted Tier-1 access to cell-line repository."

Story · Row 1 · 04 Feb 2019
05 · SOURCE
Bundle page + transcript

Employment contract p.3 · client interview 00:00:12 — Dr. Ong.

B-A · p.003 · Tr. 00:00:12
Ready when you are

Two weeks of prep,
done in an afternoon.

Book a 30-minute walkthrough with a case of your own — or browse the other modules in depth.

Back to overview